SCAI 2021 Late-breaking Clinical Study Results
SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI.
April 29, 2021 Here is the list of late-breaking study presentations and links to articles about each of them from the Society for Cardiovascular Angiography and Interventions (SCAI) 2021 Scientific Sessions Virtual Conference, which took place April 28 - May 1. Sessions share the latest advances in interventional cardiology and featured late-breaking clinical research. Find the entire virtual meeting program and links to the archived on-demand sessions at www.scai.org/scai2021.
Some 80 hospitals participated in study of 406 patients
Henry Ford patients told story of blacking out and waking up in the hospital
Screenshot
David Johnson, Henry Ford patient (center), Dr. Sarah Gorgis (right) and Dr. Mohammad Zaidan, two interventional cardiologists at Henry Ford Hospital, talk about the Detroit procedure during a Zoom session.
A top cardiologist and researcher at Henry Ford Health System in Detroit is calling on at least 1,000 hospitals in the U.S. to adopt a life-saving therapy that a national study is showing can increase survival rates of patients with severe heart attacks to 71 percent from about 50 percent before the treatment was introduced.
April 30, 2021
Two new studies document the progress that’s been made in creating a consistent approach to cardiogenic shock care, and point to new directions as the field evolves. Both were released this week in a late-breaking session of the Society for Cardiovascular Angiography and Interventions (SCAI) 2021 virtual meeting.
Jacob Jentzer, MD (Mayo Clinic, Rochester, MN), presented pooled data confirming that SCAI’s classification system for shock severity tracks closely with mortality risk. Babar Basir, DO (Henry Ford Health System, Detroit, MI), shared final results from the National Cardiogenic Shock Initiative (NCSI) showing that an algorithm emphasizing early use of mechanical circulatory support can offer better survival for patients with acute MI complicated by cardiogenic shock (AMICS).
Large heart attack study shows increased survival rates in patients with cardiogenic shock
The results of a large, national heart attack study show that patients with a deadly complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at Henry Ford Hospital in collaboration with four metro Detroit hospitals.
Cardiogenic shock is a critical condition in which the heart is unable to pump enough blood to sustain the body s needs, depriving vital organs of blood supply and can cause them to eventually cease functioning. The typical survival rate of this deadly complication during a heart attack has historically hovered around 50%.
Cardiologists at Henry Ford Hospital Led the Development of Shock Treatment Protocol
DETROIT (April 28, 2021) – The results of a large, national heart attack study show that patients with a deadly complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at Henry Ford Hospital in
Cardiogenic shock is a critical condition in which the heart is unable to pump enough blood to sustain the body’s needs, depriving vital organs of blood supply and can cause them to eventually cease functioning. The typical survival rate of this deadly complication during a heart attack has historically hovered around 50%.